XERIS BIOPHARMA HOLDINGS, INC. (XERS) /
The cash flow of XERIS BIOPHARMA HOLDINGS, INC. over the past 6 years
Chart XERIS BIOPHARMA HOLDINGS, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2020–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, XERIS BIOPHARMA HOLDINGS, INC.'s operating cash flow was $28.63M and its capital expenditures $696K, leaving free cash flow of $27.93M. Free cash flow was above zero in 1 of the 6 years shown. It ranged from -$103.42M in fiscal 2022 to $27.93M in fiscal 2025. Capital expenditures were highest in fiscal 2023, at $2.26M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $28.63M | $696K | $27.93M |
| 2024ended Dec 31, 2024 | -$36.98M | $868K | -$37.85M |
| 2023ended Dec 31, 2023 | -$47.02M | $2.26M | -$49.29M |
| 2022ended Dec 31, 2022 | -$102.89M | $524K | -$103.42M |
| 2021ended Dec 31, 2021 | -$95.53M | $1.08M | -$96.62M |
| 2020ended Dec 31, 2020 | -$80.56M | $377K | -$80.94M |
Fiscal years as XERIS BIOPHARMA HOLDINGS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on XERIS BIOPHARMA HOLDINGS, INC.
- The revenue of XERIS BIOPHARMA HOLDINGS, INC.
- The profitability of XERIS BIOPHARMA HOLDINGS, INC.
- The debt of XERIS BIOPHARMA HOLDINGS, INC.
- All of XERIS BIOPHARMA HOLDINGS, INC.'s financials, charted
Companies of a similar size
- VCELVERICEL CORPORATION
- BANCBANC OF CALIFORNIA, INC.
- DRHDIAMONDROCK HOSPITALITY CO
- CIFRCipher Digital Inc.
- ATRCAtriCure, Inc.
Not investment advice. This page shows what XERIS BIOPHARMA HOLDINGS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.